Role of insulin in the hyperandrogenemia of lean women with polycystic ovary syndrome and normal insulin sensitivity

Fertility and Sterility

Volumn 88, Issue 4, 2007, Pages 886-893

  Baillargeon, Jean Patrice ^a   Carpentier, André ^a  

^a UNIVERSITÉ DE SHERBROOKE   (Canada)

Author keywords

hyperandrogenemia; insulin action; insulin sensitivity; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; DIAZOXIDE; FIBRINOGEN; GLUCOSE; INSULIN; LEUPRORELIN; LIPID; LUTEINIZING HORMONE; PLASMINOGEN ACTIVATOR INHIBITOR 1; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

ADULT; ANTHROPOMETRIC PARAMETERS; ARTICLE; BODY MASS; CLINICAL ARTICLE; CLINICAL RESEARCH; CONTROLLED STUDY; FEMALE; FOLLOW UP; GLUCOSE METABOLISM; HORMONAL REGULATION; HUMAN; HYPERANDROGENISM; HYPERINSULINEMIA; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN SENSITIVITY; LEAN BODY WEIGHT; OVARY POLYCYSTIC DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGULATORY MECHANISM;

ADOLESCENT; ADULT; ANDROGENS; ANDROSTENEDIONE; DIAZOXIDE; FEMALE; HUMANS; INSULIN; LEUPROLIDE; LUTEINIZING HORMONE; POLYCYSTIC OVARY SYNDROME; PROSPECTIVE STUDIES; SEX HORMONE-BINDING GLOBULIN; TESTOSTERONE; THINNESS;

EID: 34848839212     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2006.12.055     Document Type: Article

References (25)

1. Baillargeon J.P., Iuorno M.J., and Nestler J.E. Insulin sensitizers for polycystic ovary syndrome. Clin Obstet Gynecol 46 (2003) 325-340
2. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
3. Nestler J.E., Jakubowicz D.J., de Vargas A.F., Brik C., Quintero N., and Medina F. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab 83 (1998) 2001-2005
4. Willis D., Mason H., Gilling-Smith C., and Franks S. Modulation by insulin of follicle-stimulating hormone and luteinizing hormone actions in human granulosa cells of normal and polycystic ovaries. J Clin Endocrinol Metab 81 (1996) 302-309
5. Gilling-Smith C., Story H., Rogers V., and Franks S. Evidence for a primary abnormality of thecal cell steroidogenesis in the polycystic ovary syndrome. Clin Endocrinol (Oxf) 47 (1997) 93-99
6. Nestler J.E., Barlascini C.O., Matt D.W., Steingold K.A., Plymate S.R., Clore J.N., et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68 (1989) 1027-1032
7. Ciotta L., Calogero A.E., Farina M., De Leo V., la Marca A., and Cianci A. Clinical, endocrine and metabolic effects of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance. Hum Reprod 16 (2001) 2066-2072
8. Nestler J.E., and Jakubowicz D.J. Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome. N Engl J Med 335 (1996) 617-623
9. Ehrmann D.A., Schneider D.J., Sobel B.E., Cavaghan M.K., Imperial J., Rosenfield R.L., et al. Troglitazone improves defects in insulin action, insulin secretion, ovarian steroidogenesis, and fibrinolysis in women with polycystic ovary syndrome. J Clin Endocrinol Metab 82 (1997) 2108-2116
10. Baillargeon J.P., Jakubowicz D.J., Iuorno M.J., Jakubowicz S., and Nestler J.E. Effects of metformin and rosiglitazone, alone and in combination, in lean women with polycystic ovary syndrome and normal indices of insulin sensitivity. Fertil Steril 82 (2004) 893-902
11. Nestler J.E., Singh R., Matt D.W., Clore J.N., and Blackard W.G. Suppression of serum insulin level by diazoxide does not alter serum testosterone or sex hormone-binding globulin levels in healthy, nonobese women. Am J Obstet Gynecol 163 4 Pt 1 (1990) 1243-1246
12. Matsuda M., and DeFronzo R.A. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22 (1999) 1462-1470
13. Legro R.S., Finegood D., and Dunaif A. A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome. J Clin Endocrinol Metab 83 (1998) 2694-2698
14. DeFronzo R.A., Tobin J.D., and Andres R. Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237 (1979) E214-E223
15. Sodergard R., Backstrom T., Shanbhag V., and Carstensen H. Calculation of free and bound fractions of testosterone and estradiol-17 beta to human plasma proteins at body temperature. J Steroid Biochem 16 (1982) 801-810
16. Friedewald W.T., Levy R.I., and Fredrickson D.S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18 (1972) 499-502
17. Dunaif A., Segal K.R., Futterweit W., and Dobrjansky A. Profound peripheral insulin resistance, independent of obesity, in polycystic ovary syndrome. Diabetes 38 (1989) 1165-1174
18. Nestler J.E., Powers L.P., Matt D.W., Steingold K.A., Plymate S.R., Rittmaster R.S., et al. A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome. J Clin Endocrinol Metab 72 (1991) 83-89
19. Hoekstra J.B., van Rijn H.J., Erkelens D.W., and Thijssen J.H. C-Peptide. Diabetes Care 5 (1982) 438-446
20. Faber O.K., and Binder C. C-Peptide: an index of insulin secretion. Diabetes Metab Rev 2 (1986) 331-345
21. Nestler J.E., Barlascini C.O., Matt D.W., Steingold K.A., Plymate S.R., Clore J.N., et al. Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J Clin Endocrinol Metab 68 (1989) 1027-1032
22. Dunaif A., Green G., Futterweit W., and Dobrjansky A. Suppression of hyperandrogenism does not improve peripheral or hepatic insulin resistance in the polycystic ovary syndrome. J Clin Endocrinol Metab 70 (1990) 699-704
23. Lasco A., Cucinotta D., Gigante A., Denuzzo G., Pedulla M., Trifiletti A., et al. No changes of peripheral insulin resistance in polycystic ovary syndrome after long-term reduction of endogenous androgens with leuprolide. Eur J Endocrinol 133 (1995) 718-722
24. Baillargeon J.P., and Nestler J.E. Polycystic ovary syndrome: a syndrome of ovarian hypersensitivity to insulin?. J Clin Endocrinol Metab 91 (2006) 22-24
25. Wu X.K., Zhou S.Y., Liu J.X., Pollanen P., Sallinen K., Makinen M., et al. Selective ovary resistance to insulin signaling in women with polycystic ovary syndrome. Fertil Steril 80 (2003) 954-965